These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
821 related items for PubMed ID: 24258574
61. [Stereotactic radiotherapy is established treatment in localized non-small cell lung cancer]. Sailas L, Virsunen H. Duodecim; 2016; 132(6):571-5. PubMed ID: 27132296 [Abstract] [Full Text] [Related]
62. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL. Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):950-8. PubMed ID: 19801106 [Abstract] [Full Text] [Related]
63. Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre. Wood A, Aynsley E, Kumar G, Masinghe S, Anderson M, Veeratterapillay J, Huntley C, Blower A, Green J, Johnson D, Daniel J, Curtis H, Reynolds J, Turnbull M, Harland K, Swingler A, Banham E, Burke K, Bradley J, Greenhalgh A, Peedell C. Clin Oncol (R Coll Radiol); 2021 May 01; 33(5):283-291. PubMed ID: 33341333 [Abstract] [Full Text] [Related]
64. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer. Suppiah S, Linden P, Robke J, Schroeder C, Yao M, Machtay M, Lo SS. Expert Rev Anticancer Ther; 2012 Nov 01; 12(11):1375-7. PubMed ID: 23249103 [No Abstract] [Full Text] [Related]
65. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. Puri V, Crabtree TD, Kymes S, Gregory M, Bell J, Bradley JD, Robinson C, Patterson GA, Kreisel D, Krupnick AS, Meyers BF. J Thorac Cardiovasc Surg; 2012 Feb 01; 143(2):428-36. PubMed ID: 22169443 [Abstract] [Full Text] [Related]
66. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY. Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):117-25. PubMed ID: 16765528 [Abstract] [Full Text] [Related]
68. Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead. Zhang J, Kong L, Jiao Q, Li M, Yu J. Cancer Lett; 2017 Aug 10; 401():46-52. PubMed ID: 28526616 [Abstract] [Full Text] [Related]
70. Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer - A Done Deal? Gulstene S, Ruwanpura T, Palma D, Joseph N. Clin Oncol (R Coll Radiol); 2022 Nov 10; 34(11):733-740. PubMed ID: 36050221 [Abstract] [Full Text] [Related]
71. Radical treatment of non-small cell lung cancer during the last 5 years. McCloskey P, Balduyck B, Van Schil PE, Faivre-Finn C, O'Brien M. Eur J Cancer; 2013 May 10; 49(7):1555-64. PubMed ID: 23352436 [Abstract] [Full Text] [Related]